TRANSCURE BIOSERVICES
TransCure bioServices has developped unique Research & Development (R&D) platforms, called the Humanized Immune System (HIS) and Human Immunodeficiency Virus (HIV) mouse models. They provide access to these platforms as a fee-for-service for the pharmaceutical companies, biotechs as well as academic laboratories which profile new drugs targeting immuno-related diseases and novel anti-HIV/AIDS therapies.
TRANSCURE BIOSERVICES
Industry:
Biotechnology Health Care Medical
Founded:
2012-01-01
Address:
Carouge, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.transcurebioservices.com
Total Employee:
1+
Status:
Active
Contact:
079 955 64 56
Email Addresses:
[email protected]
Total Funding:
3.97 M USD
Technology used in webpage:
SPF Content Delivery Network Amazon OpenResty AWS Global Accelerator Hetzner Bodis
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Praxis Precision Medicines
Praxis Precision Medicines offers drug development services.
Current Employees Featured
Founder
Investors List
Arbevel
Arbevel investment in Venture Round - TransCure bioServices
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - TransCure bioServices
Venture Kick
Venture Kick investment in Pre Seed Round - TransCure bioServices
Venture Kick
Venture Kick investment in Grant - TransCure bioServices
Venture Kick
Venture Kick investment in Grant - TransCure bioServices
Official Site Inspections
http://www.transcurebioservices.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
